Skip to search formSkip to main contentSkip to account menu

cernilton

National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Plant ExtractsSecale

Narrower (2)

cernitin GBXcernitin T60

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Oral administration of cernitin pollen extract (Cernilton®) for 30 days might be useful to avoid unnecessary biopsy in prostate biopsy candidates: A preliminary study
To assess the effect of cernitin pollen extract on serum prostate‐specific antigen level prostate biopsy candidates, and to… 
2012
2012
Usefulness of Cernilton in the treatment of benign prostatic hyperplasia
A total of 89 patients with benign prostatic hyperplasia (BPH) were treated pharmacologically for 4 months: 51 received Cernilton… 
2006
2006
Usefulness of Cernilton in the treatment of benign prostatic hyperplasia
A total of 89 patients with benign prostatic hyperplasia (BPH) were treated pharmacologically for 4 months: 51 received Cernilton… 
1992
1992
[Clinical effect of Cernilton in chronic prostatitis].
Twenty-five patients with chronic prostatitis were given Cernilton tablets. Improvement of subjective symptoms and objective… 
1990
1990
[Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
A multiple center double blind study was performed to study the effectiveness of Cernilton (CN) on benign prostatic hypertrophy… 
1988
1988
Konservative Therapie der benignen Prostata-Hyperplasie (BPH) mit Cernilton®N. Ergebnisse einer plazebokontrollierten Doppelblindstudie
Confirmation de l'efficacite de cet extrait de pollen dans l'adenome aux stades II et III, en ce qui concerne la symptomatologie… 
1988
1988
[A long-term therapeutic experience with Cernilton in chronic prostatitis].
Thirty-two patients with chronic prostatitis were given 6 tables of Cernilton daily for 12.6 weeks on the average. Improvement of… 
1986
1986
[Clinical evaluation of Cernilton in benign prostatic hypertrophy].
Twenty patients with benign prostatic hypertrophy were treated with Cernilton, 6 tablets a day for an average of 13.2 weeks… 
1985
1985
[Clinical evaluation of Cernilton on benign prostatic hyperplasia].
Twenty-two patients whose average age was 67 years and who had benign prostatic hyperplasia of stage I and II were treated with… 
1967
1967
[Use of "Cernilton" in patients with prostatic hypertrophy].
Today the only radical therapy for prostatic hypertrophy is prostatectomy or transurethral prostatectomy. Prostatic hypertrophy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)